|
|
Volumn 67, Issue 15, 2007, Pages 2289-
|
|
Maraviroc: A viewpoint
|
|
Author keywords
Adis Drug Profiles; HIV infections; Maraviroc, general; Research and development
|
|
Indexed keywords
APLAVIROC;
CHEMOKINE RECEPTOR CCR5 ANTAGONIST;
CHEMOKINE RECEPTOR CXCR4;
MARAVIROC;
VICRIVIROC;
ANTIVIRAL ACTIVITY;
CD4 LYMPHOCYTE COUNT;
DRUG CLASSIFICATION;
DRUG WITHDRAWAL;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LIVER TOXICITY;
NOTE;
PREVALENCE;
RISK REDUCTION;
TREATMENT DURATION;
VIRUS RESISTANCE;
|
|
EID: 35048814879
PISSN: 00126667
EISSN: 00126667
Source Type: Journal
DOI: 10.2165/00003495-200767150-00012 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|
